Basic Details
| Item | Value |
|---|---|
| Title | Biotech Due-Diligence Toolkit: Notion/Excel Template for Catalyst-Driven Investing |
| Type | Product |
| Difficulty | 20 |
| Ideal Capital | 500 |
| ROI | 200% |
| ETA on ROI | 3 |
| Target Audience | Retail DIY biotech investors and finance students |
| Target Countries | Global English-speaking markets, primarily USA, UK, EU, Switzerland |
| Target Demographics | Ages 25-55, male and female, self-directed investors, interests in stock analysis, spreadsheets, Notion productivity, and biotech |
| Description | Create and sell a digital due-diligence toolkit (Notion template + Excel workbook) for analyzing biotech stocks. It includes: a catalyst calendar, clinical-trial success probability checklist, revenue/royalty projection model for companies like Basilea (Cresemba/Zevtera royalties), valuation multiples, risk checklist, and a pre-built Basilea case study using the H1 2026 results and Fosmanogepix Phase-3 timeline. Package as a downloadable ZIP with video walkthroughs. Sell via Gumroad or LemonSqueezy; deliver instantly. Upsell a monthly updated catalyst calendar for $9/month. |
| Monetization | One-time purchase of $49 for the basic toolkit and $99 for the pro version with video course; recurring $9/month for updated catalyst data. |
| Pros |
|
| Cons |
|
